Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bayer AG sell kschabe

Start price
€40.83
15.11.23 / 60%
Target price
€35.00
15.11.24
Performance (%)
-19.02%
End price
€33.06
22.11.23
Summary
This prediction ended on 22.11.23 with a price of €33.06. The price of Bayer AG decreased from the start of the prediction. Compared to the start price this resulted in a performance of -19.02%. kschabe has 60% into this prediction

Bayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.

Performance without dividends (%)
Name 1w 1m
Bayer AG 1.409% 1.409%
iShares Core DAX® 2.912% 3.726%
iShares Nasdaq 100 2.129% 3.380%
iShares Nikkei 225® 2.078% 7.286%
iShares S&P 500 1.738% 4.093%

According to kschabe what are the pros and cons of Bayer AG for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment
Higher risks for its business

Comments by kschabe for this prediction

In the thread Bayer AG diskutieren
Prediction Sell
Perf. (%) -19.02%
Target price 35.000
Change
Ends at 15.11.24

Sell mit Kursziel 35,0